PL378577A1 - Pochodne estrogenu jako inhibitory sulfatazy steroidowej - Google Patents

Pochodne estrogenu jako inhibitory sulfatazy steroidowej

Info

Publication number: PL378577A1
Authority: PL; Poland
Prior art keywords: group; inhibitors; ring system; steroid sulphatase; oestrogen derivatives
Prior art date: 2003-03-24

Application number

PL378577A

Other languages

English (en)

Inventor

Mathew Leese

Alan Purohit

Michael John Reed

Simon Paul Newman

Surinder Kumar Chander

Fabrice Jourdan

Barry Victor Lloyd Potter

Original Assignee

Sterix Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-24

Filing date

2004-02-20

Publication date

2006-05-02

2003-03-24 Priority claimed from GB0306717A external-priority patent/GB0306717D0/en

2003-07-07 Priority claimed from GB0315885A external-priority patent/GB0315885D0/en

2004-02-20 Application filed by Sterix Limited filed Critical Sterix Limited

2006-05-02 Publication of PL378577A1 publication Critical patent/PL378577A1/pl

Links

102000009134 Steryl-Sulfatase Human genes 0.000 title 1
108010087999 Steryl-Sulfatase Proteins 0.000 title 1
239000000262 estrogen Substances 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
230000003637 steroidlike Effects 0.000 abstract 3
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical group OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 abstract 1
150000001336 alkenes Chemical class 0.000 abstract 1
150000001412 amines Chemical class 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
125000005647 linker group Chemical group 0.000 abstract 1
IOVCWXUNBOPUCH-UHFFFAOYSA-M nitrite group Chemical group N(=O)[O-] IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 abstract 1
IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical group NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 abstract 1
125000000565 sulfonamide group Chemical group 0.000 abstract 1
125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Virology (AREA)
Psychiatry (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Transplantation (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Enzymes And Modification Thereof (AREA)

PL378577A 2003-03-24 2004-02-20 Pochodne estrogenu jako inhibitory sulfatazy steroidowej PL378577A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0306717A GB0306717D0 (en)	2003-03-24	2003-03-24	Compound
GB0315885A GB0315885D0 (en)	2003-07-07	2003-07-07	Compound

Publications (1)

Publication Number	Publication Date
PL378577A1 true PL378577A1 (pl)	2006-05-02

Family

ID=33099976

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL378577A PL378577A1 (pl)	2003-03-24	2004-02-20	Pochodne estrogenu jako inhibitory sulfatazy steroidowej

Country Status (14)

Country	Link
US (1)	US7893284B2 (pl)
EP (1)	EP1608671B1 (pl)
JP (1)	JP4719144B2 (pl)
AT (1)	ATE454395T1 (pl)
AU (1)	AU2004224053B2 (pl)
BR (1)	BRPI0408703A (pl)
CA (1)	CA2520142C (pl)
DE (1)	DE602004024966D1 (pl)
DK (1)	DK1608671T3 (pl)
EA (1)	EA011123B1 (pl)
ES (1)	ES2339450T3 (pl)
MX (1)	MXPA05010339A (pl)
PL (1)	PL378577A1 (pl)
WO (1)	WO2004085459A1 (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0113920D0 (en)	2001-06-07	2001-08-01	Sterix Ltd	Composition
US8030298B2 (en)	2005-05-26	2011-10-04	Abbott Products Gmbh	17β-HSD1 and STS inhibitors
US8288367B2 (en)	2006-11-30	2012-10-16	Solvay Pharmaceuticals Gmbh	Substituted estratriene derivatives as 17BETA HSD inhibitors
WO2008090517A2 (en) *	2007-01-26	2008-07-31	Piramal Life Sciences Limited	Enriched plant extract, compound, and methods for the treatment of proliferative disorders
EP2149371A1 (en)	2008-07-28	2010-02-03	PregLem S.A.	Use of steroid sulfatase inhibitors for the treatment of preterm labor
US20110190323A1 (en)	2008-08-28	2011-08-04	President And Fellows Of Harvard College	Cortistatin analogues and syntheses thereof
WO2010123545A2 (en) *	2009-04-22	2010-10-28	President And Fellows Of Harvard College	Angiogenesis inhibitors
WO2012116290A2 (en) *	2011-02-25	2012-08-30	Washington University	Neuroactive 17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
CA3152410A1 (en)	2011-10-14	2013-04-18	Sage Therapeutics, Inc.	3,3-disubstituted 19-nor pregnane compounds, compositions, and uses thereof for the treatment of cns related disorders
TR201808616T4 (tr)	2012-12-18	2018-07-23	Sage Therapeutics Inc	Nöroaktif 19-alkoksi-17-ikameli steroidler, bunların ön ilaçları ve bunları kullanan tedavi yöntemleri.
US9512170B2 (en)	2013-03-01	2016-12-06	Washington University	Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
US9365502B2 (en)	2013-03-11	2016-06-14	Washington University	Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
US9562026B2 (en)	2013-03-14	2017-02-07	Washington University	Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
RU2019126333A (ru)	2013-04-17	2019-10-08	Сейдж Терапьютикс, Инк.	19-нор нейроактивные стероиды и способы их применения
CN113527400B (zh)	2013-04-17	2024-06-28	萨奇治疗股份有限公司	19-去甲c3,3-二取代的c21-n-吡唑基类固醇及其使用方法
WO2014169831A1 (en)	2013-04-17	2014-10-23	Sage Therapeutics, Inc.	19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
US20160068563A1 (en)	2013-04-17	2016-03-10	Boyd L. Harrison	19-nor neuroactive steroids and methods of use thereof
WO2015010054A2 (en)	2013-07-19	2015-01-22	Sage Therapeutics, Inc.	Neuroactive steroids, compositions, and uses thereof
AU2014308621C1 (en)	2013-08-23	2022-01-06	Sage Therapeutics, Inc.	Neuroactive steroids, compositions, and uses thereof
CA2934819A1 (en)	2013-12-24	2015-07-02	President And Fellows Of Harvard College	Cortistatin analogues and syntheses and uses thereof
WO2015195962A1 (en)	2014-06-18	2015-12-23	Sage Therapeutics, Inc.	Neuroactive steroids, compositions, and uses thereof
MX2021004492A (es)	2014-10-16	2022-12-05	Sage Therapeutics Inc	Composiciones para el tratamiento de trastornos del snc.
SMT202000414T1 (it)	2014-10-16	2020-09-10	Sage Therapeutics Inc	Composizioni e metodi per trattare disturbi del snc
ME03749B (me)	2014-11-27	2021-04-20	Sage Therapeutics Inc	KOMPOZICIJE I POSTUPCIZA LEČENJE POREMEĆAJA CNS-a
DK3250210T3 (da)	2015-01-26	2021-03-08	Sage Therapeutics Inc	Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
JP6875996B2 (ja)	2015-02-20	2021-05-26	セージセラピューティクス，インコーポレイテッド	神経刺激性ステロイド、組成物、およびその使用
WO2016182932A1 (en)	2015-05-08	2016-11-17	President And Fellows Of Harvard College	Cortistatin analogues, syntheses, and uses thereof
WO2017004411A1 (en)	2015-07-01	2017-01-05	President And Fellows Of Harvard College	Cortistatin analogues and syntheses and uses thereof
US10872414B2 (en) *	2016-06-15	2020-12-22	Sony Corporation	Information processing apparatus, observation system, observation method, and program
WO2018013613A1 (en)	2016-07-11	2018-01-18	Sage Therapeutics, Inc.	C17, c20, and c21 substituted neuroactive steroids and their methods of use
CA3030420C (en)	2016-07-11	2025-11-18	Sage Therapeutics, Inc.	C7, C12 AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND ASSOCIATED METHODS OF USE
CN114206900A (zh)	2019-05-31	2022-03-18	萨奇治疗股份有限公司	神经活性类固醇及其组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4994439A (en) *	1989-01-19	1991-02-19	California Biotechnology Inc.	Transmembrane formulations for drug administration
DE19723794A1 (de) *	1997-06-06	1998-12-10	Jenapharm Gmbh	Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
US6288050B1 (en) *	1997-07-18	2001-09-11	Duquesne University Of The Holy Ghost	Steroid sulfatase inhibitors and methods for making and using the same
GB2331987B (en) *	1997-12-04	2002-11-27	Imperial College	Polycyclic sulphamate inhibitors of oestrone sulphatase
US6046186A (en)	1997-12-24	2000-04-04	Sri International	Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
ATE401896T1 (de) *	1998-06-10	2008-08-15	Sterix Ltd	Pharmazeutische zusammensetzungen mit tumor nekrose faktor und 2-methoxyestron-3-o-sulphamat als estrone sulphatasehemmern
JP5042411B2 (ja) *	1999-04-30	2012-10-03	ステリックスリミテッド	抗腫瘍剤としてのエストロン誘導体の使用
EP1284272A4 (en) *	2000-04-24	2003-09-10	Kyowa Hakko Kogyo Kk	ESTRA-1,3,5 (10) -TRIENE DERIVATIVES
DK1287017T3 (da) *	2000-05-11	2005-12-05	Res Inst Medicine Chem	2-substituerede pregna-1,3,5(10)-trien- og chola-1,3,5(10)-trienderivater og deres biologiske aktivitet
GB0020498D0 (en) *	2000-08-18	2000-10-11	Sterix Ltd	Compound
EP1309605A1 (en) *	2000-08-18	2003-05-14	The Board Of Trustees Of The University Of Illinois	Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
WO2002062347A1 (en)	2001-02-05	2002-08-15	Oncology Sciences Corporation	Method and composition of novel compounds for the therapy and targeting of the primary modalities of cancer cell proliferation and homeostasis
GB0421106D0 (en) *	2004-09-22	2004-10-27	Sterix Ltd	Compound

2004
- 2004-02-20 WO PCT/GB2004/000705 patent/WO2004085459A1/en not_active Ceased
- 2004-02-20 AU AU2004224053A patent/AU2004224053B2/en not_active Ceased
- 2004-02-20 BR BRPI0408703-8A patent/BRPI0408703A/pt not_active IP Right Cessation
- 2004-02-20 EP EP04713124A patent/EP1608671B1/en not_active Expired - Lifetime
- 2004-02-20 EA EA200501426A patent/EA011123B1/ru not_active IP Right Cessation
- 2004-02-20 AT AT04713124T patent/ATE454395T1/de not_active IP Right Cessation
- 2004-02-20 ES ES04713124T patent/ES2339450T3/es not_active Expired - Lifetime
- 2004-02-20 MX MXPA05010339A patent/MXPA05010339A/es active IP Right Grant
- 2004-02-20 DE DE602004024966T patent/DE602004024966D1/de not_active Expired - Lifetime
- 2004-02-20 CA CA2520142A patent/CA2520142C/en not_active Expired - Fee Related
- 2004-02-20 PL PL378577A patent/PL378577A1/pl not_active Application Discontinuation
- 2004-02-20 JP JP2006505892A patent/JP4719144B2/ja not_active Expired - Fee Related
- 2004-02-20 DK DK04713124.8T patent/DK1608671T3/da active
2005
- 2005-09-23 US US11/233,945 patent/US7893284B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1608671B1 (en)	2010-01-06
HK1082258A1 (en)	2006-06-02
WO2004085459A1 (en)	2004-10-07
EP1608671A1 (en)	2005-12-28
EA200501426A1 (ru)	2006-06-30
US7893284B2 (en)	2011-02-22
AU2004224053B2 (en)	2011-06-09
MXPA05010339A (es)	2005-12-14
JP2006521335A (ja)	2006-09-21
JP4719144B2 (ja)	2011-07-06
DE602004024966D1 (de)	2010-02-25
US20060094696A1 (en)	2006-05-04
EA011123B1 (ru)	2008-12-30
ATE454395T1 (de)	2010-01-15
AU2004224053A1 (en)	2004-10-07
CA2520142C (en)	2011-01-04
CA2520142A1 (en)	2004-10-07
DK1608671T3 (da)	2010-05-10
ES2339450T3 (es)	2010-05-20
BRPI0408703A (pt)	2006-03-07

Legal Events

Date	Code	Title	Description
2013-10-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
MXPA05010339A (es)	2005-12-14	Derivados de estrogeno como inhibidores de la esteroide sulfatasa.
HRP20090195T1 (hr)	2009-05-31	Inhibitori mitotičkih kinezina
CY1110237T1 (el)	2015-01-14	Συνθεση οιστετρολης δια στεροειδων προερχομενων απο οιστρονη
ES2194446T3 (es)	2003-11-16	Derivados de bibiclooctano utilizados como plastificantes.
DOP2011000301A (es)	2011-10-31	Derivados de azaadamantano y metodos de uso de los mismos
ES2185338T3 (es)	2003-04-16	Derivados de fumagilol y procedimientos para su fabricacion.
GT200100007A (es)	2001-10-19	Antagonistas del factor liberador de corticotropina.
DE60032440D1 (de)	2007-02-01	Halterung für die Brennkammer einer Gasturbine
CO5231161A1 (es)	2002-12-27	4-aminopicolinatos y su uso como herbicidas
HN2001000146A (es)	2002-01-11	Derivados de pirazol
TR200101906T2 (tr)	2001-12-21	Antiviral ajanlar olarak kuinolinkarboksamitler
DK1284737T5 (da)	2007-09-24	Vandoplöselige prolægemidler af azolforbindelser
MXPA04003886A (es)	2004-07-08	Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
PT1087986E (pt)	2002-08-30	Undecanoato de 7alfa-metil-19-nortestosterona com actividade androgenica
HRP20090474T1 (hr)	2009-10-31	Postupak i intermedijeri za sintezu kaspofungina
AR064306A1 (es)	2009-03-25	Antagonistas del receptor de angiotensina ii
UA88008C2 (en)	2009-09-10	Water-soluble prodrugs
AR042404A2 (es)	2005-06-22	Compuestos derivados de anilina
GB2423992A (en)	2006-09-13	Alkoxylated alkylphenol-formaldehyde-diamine polymer
MX2008011292A (es)	2008-09-10	Compuestos esteroidales como inhibidores de esteroide sulfatasa.
PA8519801A1 (es)	2002-04-25	Nuevo procedimiento para la preparacion de pirazolopirimidinonas
UY26574A1 (es)	2001-04-30	" procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
DK1255745T3 (da)	2004-05-17	Syntese af vandoplöseligt 9-dihydro-paclitaxel afledninger fra 9-dihydro-13-acetylbaccatin III
PT1448592E (pt)	2006-07-31	Compostos esteroides para inibicao da esteroide sulfatase
ZA9811380B (pl)	1999-06-14